Quest Diagnostics (DGX) Consolidated Net Income (2009 - 2026)

Quest Diagnostics (DGX) has 14 years of Consolidated Net Income data on file, last reported at $260.0 million in Q1 2026.

• Quarterly Consolidated Net Income rose 19.82% year-over-year to $260.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 13.93% YoY) and the FY2025 annual result came in at $1.0 billion, up 11.31% from the prior year.
• Consolidated Net Income grew to $260.0 million in Q1 2026 per DGX's latest filing, from $249.0 million in the prior quarter.
• The five-year high for Consolidated Net Income was $342.0 million in Q1 2022, with the low at $113.0 million in Q4 2022.
• Average Consolidated Net Income over 5 years is $236.4 million, with a median of $240.0 million recorded in 2024.
• Year-over-year, Consolidated Net Income plunged 70.88% in 2022 and jumped 74.34% in 2023.
• Quest Diagnostics' Consolidated Net Income stood at $113.0 million in 2022, then jumped by 74.34% to $197.0 million in 2023, then grew by 17.26% to $231.0 million in 2024, then climbed by 7.79% to $249.0 million in 2025, then gained by 4.42% to $260.0 million in 2026.
• Business Quant data shows DGX's Consolidated Net Income at $260.0 million in Q1 2026, $249.0 million in Q4 2025, and $251.0 million in Q3 2025.